| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/10/2012 | US8093223 RIP140 regulation of diabetes |
| 01/10/2012 | US8093216 Diagnosis and classification of cancer; obtain tissue sample, lyse cells, screen lysate for expression of tumor polypeptide, presence of polypeptide indicates tumor |
| 01/10/2012 | US8093209 Methods of suppressing microglial activation and systemic inflammatory responses |
| 01/10/2012 | US8093208 Therapeutic peptides for the treatment of metastatic cancer |
| 01/10/2012 | US8093046 CVN-12p1: a recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions |
| 01/10/2012 | US8093044 Methods for identifying inhibitors of botulinum neurotoxins |
| 01/10/2012 | US8093034 Fed batch culture methods for streptococci |
| 01/10/2012 | US8093033 Multi plasmid system for the production of influenza virus |
| 01/10/2012 | US8093010 Angiogenesis inhibiting molecules, their selection, production and their use in the treatment of cancer |
| 01/10/2012 | US8093008 Characterization of granulocytic ehrlichia and methods of use |
| 01/10/2012 | US8092989 Targeting the histone code as a bacterial strategy for selectively modulating gene expression |
| 01/10/2012 | US8092813 Polychlorinated biphenyls and squalene-containing adjuvants |
| 01/10/2012 | US8092812 Methods and compositions for immunization against chlamydial infection and disease |
| 01/10/2012 | US8092811 Interaction of Moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| 01/10/2012 | US8092810 Use of polypeptides having antimicrobial activity |
| 01/10/2012 | US8092809 Pseudomonas exotoxin A-like chimeric immunogens |
| 01/10/2012 | US8092808 Ovo vaccination of Campylobacter in avian species |
| 01/10/2012 | US8092807 Modified leukocyte Ig-like receptor family members (LIRs) with increased affinity for class 1 MHC and their uses in modulating T-cell activation |
| 01/10/2012 | US8092806 Chimeric proteins, their preparation and pharmaceutical compositions containing them |
| 01/10/2012 | US8092805 Dual inhibitors of HIV-1 gp-120 interactions |
| 01/10/2012 | US8092804 Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
| 01/10/2012 | US8092802 High affinity human antibodies to human IL-4 receptor |
| 01/10/2012 | US8092801 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 01/10/2012 | US8092800 Single domain monoclonal antibody for use in treatment and prevention of viral and yeast infection |
| 01/10/2012 | US8092799 Antibodies to Apo-2 receptor polypeptides |
| 01/10/2012 | US8092798 Method of increasing trabecular bone density in a patient in need thereof by an antibody against GDF-8 |
| 01/10/2012 | US8092797 using monoclonal antibody or an Fab fragment capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, age-induced macular degeneration |
| 01/10/2012 | US8092796 Monoclonal antibodies against ANGPTL4 |
| 01/10/2012 | US8092788 Compositions and methods for topical diagnostic and therapeutic transport |
| 01/10/2012 | US8092781 Treatment of sinusitis in mammals with clostridia neurotoxins |
| 01/10/2012 | US8092780 Polyvalent conjugate vaccine for cancer |
| 01/10/2012 | US8092608 Administering oligosaccharides |
| 01/10/2012 | CA2597701C Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats o11 serotype |
| 01/10/2012 | CA2455189C Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture |
| 01/10/2012 | CA2428073C Paramyxovirus vector for gene transfer to the cardiovascular system |
| 01/10/2012 | CA2419541C Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 01/10/2012 | CA2392071C Microparticle-based transfection and activation of dendritic cells |
| 01/10/2012 | CA2366314C Protein d from haemophilus influenzae as a carrier protein in combination vaccines |
| 01/10/2012 | CA2246760C Polysaccharide-peptide-conjugates |
| 01/10/2012 | CA2214102C Group o hiv-1, fragments of such viruses, and uses thereof |
| 01/05/2012 | WO2012003504A2 A system and method for cloud file management |
| 01/05/2012 | WO2012003472A1 Anti-notch1 antibodies |
| 01/05/2012 | WO2012003437A1 Treatment of vascularized pigment epithelial detachment with anti-vegf therapy |
| 01/05/2012 | WO2012003361A2 Nanoemulsion vaccines |
| 01/05/2012 | WO2012003338A1 COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET |
| 01/05/2012 | WO2012003320A2 Flavivirus host-range mutations and uses thereof |
| 01/05/2012 | WO2012003205A2 Vaccine against ehrlichia canis and associated methods |
| 01/05/2012 | WO2012003129A2 Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host |
| 01/05/2012 | WO2012002760A2 Method for treating and diagnosing cancer by using cell-derived microvesicles |
| 01/05/2012 | WO2012002388A1 Drug delivery agent to sentinel lymph node |
| 01/05/2012 | WO2012001674A1 Anti-ktpaf50 antibodies and their uses in therapeutic and diagnostic methods |
| 01/05/2012 | WO2012001179A2 Linear ige peptide epitopes of hazelnut allergen cor a 1 and celery antigen api 1 |
| 01/05/2012 | WO2012001178A1 The role of fragile x mental retardation gene and protein in cancer metastasis |
| 01/05/2012 | WO2012001101A1 Enterovirus vaccines for preventing or treating type 1 diabetes (i) |
| 01/05/2012 | WO2012001100A1 Enterovirus vaccines for preventing or treating type 1 diabetes (iii) |
| 01/05/2012 | WO2012001099A1 Enterovirus vaccines for preventing and treating type 1 diabetes (ii) |
| 01/05/2012 | WO2012001098A1 Diagnostic assay for type 1 diabetes |
| 01/05/2012 | WO2012001087A1 Antibodies that are capable of specifically binding tissue factor pathway inhibitor |
| 01/05/2012 | WO2012001004A1 Fimh vaccine against urinary tract infections (uti) |
| 01/05/2012 | WO2012000994A1 Llt-1 antibodies with new functional properties |
| 01/05/2012 | WO2012000459A1 Anti-hiv infection polypeptide, composition, and use |
| 01/05/2012 | WO2012000454A1 Truncated l1 protein of human papillomavirus type 52 |
| 01/05/2012 | WO2012000188A1 Recombinant tumor vaccine and method of producing such |
| 01/05/2012 | WO2012000082A1 Use of leukotriene b4 in combination with a toll-like receptor ligand, a rig-l-like receptor ligand or a nod-like receptor ligand to enhance the innate immune response |
| 01/05/2012 | WO2012000062A1 Diagnosis and treatment of brain tumors |
| 01/05/2012 | WO2011143318A3 Anti-fgfr2 antibodies |
| 01/05/2012 | WO2011140634A3 The n-domain of carcinoembryonic antigen and compositions, methods and uses thereof |
| 01/05/2012 | WO2011140595A3 Immunostimulatory and vaccine compositions |
| 01/05/2012 | WO2011137876A3 Adjuvanted tolerogens as a malaria vaccine |
| 01/05/2012 | WO2011116344A9 Targeting cancer stem cells |
| 01/05/2012 | WO2011109365A3 Concentrated protein formulations and uses thereof |
| 01/05/2012 | WO2011097221A3 Methods of promoting tissue growth and tissue regeneration |
| 01/05/2012 | WO2011091167A3 Lysophosphatidic acid receptor targeting for scleroderma and other fibrotic diseases |
| 01/05/2012 | WO2011091154A3 Use of human erythrocytes for prevention and treatment of cancer dissemination and growth |
| 01/05/2012 | WO2011090648A3 Inhibitors of vascular endothelial growth factor (vegf) receptors and methods of use thereof |
| 01/05/2012 | WO2011080271A3 Exosomes derived from reticulocytes infected with plasmodium sp., method for obtaining them and uses thereof |
| 01/05/2012 | WO2011074006A4 Vaccine composition |
| 01/05/2012 | US20120005777 Process for the Production of Fine Chemicals |
| 01/05/2012 | US20120005768 Circovirus Sequences Associated With Piglet Weight Loss Disease (PWD) |
| 01/05/2012 | US20120005767 Antibodies to insulin-like growth factor i receptor |
| 01/05/2012 | US20120005127 Methods for improvement of beta cell function |
| 01/05/2012 | US20120004643 Vaccines Based on Targeting Antigen to DCIR Expressed on Antigen-Presenting Cells |
| 01/05/2012 | US20120004161 Homogenous preparations of il-28 and il-29 |
| 01/05/2012 | US20120003309 Solid Dosage Forms Of Bendamustine |
| 01/05/2012 | US20120003306 Pharmaceutical composition of nanoparticles for protein drug delivery |
| 01/05/2012 | US20120003305 Oral Dosage Forms Of Bendamustine |
| 01/05/2012 | US20120003298 Methods for inducing an immune response |
| 01/05/2012 | US20120003296 New methods of treating dry eye syndrome |
| 01/05/2012 | US20120003295 Lipid a and other carbohydrate ligand analogs |
| 01/05/2012 | US20120003277 Nanoemulsion vaccines |
| 01/05/2012 | US20120003269 Compositions Produced Using Enteric Pathogens and Methods of Use |
| 01/05/2012 | US20120003268 Synergistic combination and method thereof |
| 01/05/2012 | US20120003267 Therapeutic Agents |
| 01/05/2012 | US20120003266 Virus like particle compositions and methods of use |
| 01/05/2012 | US20120003265 Immunogenic compositions for inducing an immune response to hiv |
| 01/05/2012 | US20120003264 CDNA Corresponding to the Antigenome of Nonsegmented Negative Stranded RNA Viruses and Process for the Production of Such Viruses |
| 01/05/2012 | US20120003263 Recombinant raccoon pox virus vaccine against highly pathogenic avian influenza |
| 01/05/2012 | US20120003260 Solid-Phase and Solution-Phase Synthesis of Glycosylphosphatidylinositol Glycans |
| 01/05/2012 | US20120003259 Molecule |
| 01/05/2012 | US20120003258 Mutant forms of streptolysin o |